Advanced search
Publication Cover
International Review of Psychiatry Volume 21, 2009 - Issue 2: Special Issue on Cannabis
Submit an article Journal homepage
1,446
Views
59
CrossRef citations to date
0
Altmetric
Original

Cannabinoids and psychosis

R. Andrew Sewell Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
,
Mohini Ranganathan Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut, USA; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Connecticut, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
&
Deepak Cyril D'Souza Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut, USA; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Connecticut, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USACorrespondence[email protected]
Pages 152-162 | Published online: 11 Jul 2009

Citations (59)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Seamus Fleming, John Mallett, Jamie Murphy & Mark Shevlin. (2012) Traumatic experience, cannabis use, life satisfaction, and schizotypy. Psychosis 4:2, pages 126-136.
Read now
Rachel S Newson, Hasse Karlsson & Henning Tiemeier. (2011) Epidemiological fallacies of modern psychiatric research. Nordic Journal of Psychiatry 65:4, pages 226-237.
Read now
Andreas Carlborg, Kajsa Winnerbäck, Erik G Jönsson, Jussi Jokinen & Peter Nordström. (2010) Suicide in schizophrenia. Expert Review of Neurotherapeutics 10:7, pages 1153-1164.
Read now
Brendan P. Murphy. (2010) Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia. International Review of Psychiatry 22:2, pages 202-223.
Read now

Articles from other publishers (55)

José Roque-Torres, Laura Ramírez-Martínez, Ediel O. Ramos-Meléndez, Omar García-Rodríguez, Agustín Rodríguez-López, Lourdes Guerrios & Pablo Rodríguez-Ortiz. (2023) Trends and outcomes of trauma patients positive to marijuana and cocaine. European Journal of Trauma and Emergency Surgery 49:4, pages 1969-1979.
Crossref
Carmen-Adella Sirbu, Ruxandra Georgescu, Florentina Cristina Pleşa, Alina Paunescu, Monica Marilena Ţânţu, Alina Crenguţa Nicolae, Ionut Caloianu & Marian Mitrica. (2023) Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice—A Review. American Journal of Therapeutics 30:3, pages e220-e231.
Crossref
Erin Leach, Larissa B. Fomum Mugri, Man Yee Keung, Lindsey Ouellette, Tiffany Fleeger, Thomas Sapp, Justin Houseman, Megan Hamilton & Jeffrey S. Jones. (2022) Neuropsychiatric effects of cannabis toxicity in the emergency department: A community-based study. The American Journal of Emergency Medicine 56, pages 375-377.
Crossref
Perrotta Giulio. (2020) Psychotic spectrum disorders: Definitions, classifications, neural correlates and clinical profiles. Annals of Psychiatry and Treatment, pages 070-084.
Crossref
Javier Fernández-Ruiz, Ismael Galve-Roperh, Onintza Sagredo & Manuel Guzmán. (2020) Possible therapeutic applications of cannabis in the neuropsychopharmacology field. European Neuropsychopharmacology 36, pages 217-234.
Crossref
Mohamed Tausif Siddiqui, Mohammad Bilal, Amandeep Singh, Sarah Olivier‐Cabrera, Edward Lebovics, Beth Schorr‐Lesnick, Brad Dworkin & Donald F Kirby. (2020) Prevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome. Neurogastroenterology & Motility 32:4.
Crossref
Hannah E. Brown, Yoshio Kaneko & Abigail L. Donovan. 2019. Substance Use and the Acute Psychiatric Patient. Substance Use and the Acute Psychiatric Patient 111 124 .
Anahita Bassir Nia, Claire Mann, Harsimar Kaur & Mohini Ranganathan. (2018) Cannabis Use: Neurobiological, Behavioral, and Sex/Gender Considerations. Current Behavioral Neuroscience Reports 5:4, pages 271-280.
Crossref
Kathy T. Vo, Howard Horng, Kai Li, Raymond Y. Ho, Alan H.B. Wu, Kara L. Lynch & Craig G. Smollin. (2018) Cannabis Intoxication Case Series: The Dangers of Edibles Containing Tetrahydrocannabinol. Annals of Emergency Medicine 71:3, pages 306-313.
Crossref
Jan Reuter. 2018. FAQ Psychiatrie und Psychotherapie. FAQ Psychiatrie und Psychotherapie 95 131 .
Luca Pauselli. 2018. The Complex Connection Between Cannabis and Schizophrenia. The Complex Connection Between Cannabis and Schizophrenia 183 197 .
María Rodríguez-Muñoz, Pilar Sánchez-Blázquez, Luis F. Callado, J. Javier Meana & Javier Garzón-Niño. (2017) Schizophrenia and depression, two poles of endocannabinoid system deregulation. Translational Psychiatry 7:12.
Crossref
Salvina Maria de Campos-Carli, Marcio Sobreira Araújo, Amanda Cardoso de Oliveira Silveira, Vitor Bortolo de Rezende, Natalia Pessoa Rocha, Rodrigo Ferretjans, Rafael Ribeiro-Santos, Andrea Teixeira-Carvalho, Olindo Assis Martins-Filho, Michael Berk, João Vinícius Salgado & Antonio Lucio Teixeira. (2017) Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms. Journal of Psychiatric Research 87, pages 44-52.
Crossref
V. Vindenes & J. Mørland. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies 24 32 .
Mohini Ranganathan, Jose Cortes-Briones, Rajiv Radhakrishnan, Halle Thurnauer, Beata Planeta, Patrick Skosnik, Hong Gao, David Labaree, Alexander Neumeister, Brian Pittman, Toral Surti, Yiyun Huang, Richard E. Carson & Deepak Cyril D’Souza. (2016) Reduced Brain Cannabinoid Receptor Availability in Schizophrenia. Biological Psychiatry 79:12, pages 997-1005.
Crossref
晓凤 贾. (2016) Receptors and Related Drug Development for Schizophrenia: Research Advances. Pharmacy Information 05:02, pages 19-24.
Crossref
Marco Colizzi, Conrad Iyegbe, John Powell, Gianluca Ursini, Annamaria Porcelli, Aurora Bonvino, Paolo Taurisano, Raffaella Romano, Rita Masellis, Giuseppe Blasi, Craig Morgan, Katherine Aitchison, Valeria Mondelli, Sonija Luzi, Anna Kolliakou, Anthony David, Robin M. Murray, Alessandro Bertolino & Marta Di Forti. (2015) Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophrenia Bulletin 41:5, pages 1171-1182.
Crossref
Valeria Gasperi, Daniela Evangelista, Isabella Savini, Domenico Del Principe, Luciana Avigliano, Mauro Maccarrone & Maria Valeria Catani. (2015) Downstream effects of endocannabinoid on blood cells: implications for health and disease. Cellular and Molecular Life Sciences 72:17, pages 3235-3252.
Crossref
G. N. Giordano, H. Ohlsson, K. Sundquist, J. Sundquist & K. S. Kendler. (2014) The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study. Psychological Medicine 45:2, pages 407-414.
Crossref
Kyle S. Minor, Ruth L. Firmin, Kelsey A. Bonfils, Charlotte A. Chun, Julia D. Buckner & Alex S. Cohen. (2014) Predicting creativity: The role of psychometric schizotypy and cannabis use in divergent thinking. Psychiatry Research 220:1-2, pages 205-210.
Crossref
Isabel Morales-Muñoz, Rosa Jurado-Barba, Guillermo Ponce, Isabel Martínez-Gras, Miguel Ángel Jiménez-Arriero, Stephan Moratti & Gabriel Rubio. (2014) Characterizing cannabis-induced psychosis: A study with prepulse inhibition of the startle reflex. Psychiatry Research 220:1-2, pages 535-540.
Crossref
Inge Gorynia, Markus Schwaiger & Andreas Heinz. (2014) Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients. European Archives of Psychiatry and Clinical Neuroscience 264:8, pages 683-695.
Crossref
Javier Fernández‐Ruiz, Mariluz Hernández & Yolanda García‐Movellán. 2014. Cannabinoids. Cannabinoids 175 218 .
Rodrigo Ferretjans, Salvina Maria de Campos, Rafael Ribeiro-Santos, Fernanda Carneiro Guimarães, Keliane de Oliveira, Ana Cecília Alves Cardoso, Marcio Sobreira Araújo, Andrea Teixeira-Carvalho, Olindo Assis Martins-Filho, Antonio L. Teixeira & João V. Salgado. (2014) Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia. Schizophrenia Research 156:2-3, pages 254-260.
Crossref
John Gunn & Pamela Taylor. 2014. Forensic Psychiatry. Forensic Psychiatry 801 954 .
Rajiv Radhakrishnan, Peter H. Addy, R. Andrew Sewell, Patrick D. Skosnik, Mohini Ranganathan & Deepak Cyril D’Souza. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System 423 474 .
Luca Zamengo, Giampietro Frison, Chiara Bettin & Rocco Sciarrone. (2013) Variability of cannabis potency in the Venice area (Italy): A survey over the period 2010–2012. Drug Testing and Analysis 6:1-2, pages 46-51.
Crossref
. 2013. Violence Risk‐Assessment and Management. Violence Risk‐Assessment and Management 200 223 .
Alexandre Seillier, Alex A Martinez & Andrea Giuffrida. (2013) Phencyclidine-Induced Social Withdrawal Results from Deficient Stimulation of Cannabinoid CB1 Receptors: Implications for Schizophrenia. Neuropsychopharmacology 38:9, pages 1816-1824.
Crossref
Dilshani W.N. Dissanayake, Robert Mason & Charles A. Marsden. (2013) Sensory gating, Cannabinoids and Schizophrenia. Neuropharmacology 67, pages 66-77.
Crossref
O. E. Onwuameze, K. W. Nam, E. A. Epping, T. H. Wassink, S. Ziebell, N. C. Andreasen & B.-C. Ho. (2012) MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse . Psychological Medicine 43:3, pages 619-631.
Crossref
Amir Englund, Paul D Morrison, Judith Nottage, Dominic Hague, Fergus Kane, Stefania Bonaccorso, James M Stone, Avi Reichenberg, Rudolf Brenneisen, David Holt, Amanda Feilding, Lucy Walker, Robin M Murray & Shitij Kapur. (2012) Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology 27:1, pages 19-27.
Crossref
Julien Matricon & Andrea Giuffrida. 2013. Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders 73 101 .
Gina M. Najolia, Julia D. Buckner & Alex S. Cohen. (2012) Cannabis use and schizotypy: The role of social anxiety and other negative affective states. Psychiatry Research 200:2-3, pages 660-668.
Crossref
Munish Aggarwal, Anindya Banerjee, Shubh Mohan Singh, S.K. Mattoo & D. Basu. (2012) Substance-induced psychotic disorders: 13-Year data from a de-addiction centre and their clinical implications. Asian Journal of Psychiatry 5:3, pages 220-224.
Crossref
Andrea Giuffrida & Alexandre Seillier. (2012) New insights on endocannabinoid transmission in psychomotor disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 38:1, pages 51-58.
Crossref
M. López-Gallardo, A.B. López-Rodríguez, Á. Llorente-Berzal, D. Rotllant, K. Mackie, A. Armario, R. Nadal & M.-P. Viveros. (2012) Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience 204, pages 90-103.
Crossref
Sandra L. Matheson, Alana M. Shepherd, Kristin R. Laurens & Vaughan J. Carr. (2011) A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophrenia Research 133:1-3, pages 133-142.
Crossref
Alvaro Llorente-Berzal, Sílvia Fuentes, Humberto Gagliano, Meritxell López-Gallardo, Antonio Armario, María-Paz Viveros & Roser Nadal. (2011) Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour. Addiction Biology 16:4, pages 624-637.
Crossref
Mary V. Seeman. (2010) Canada: Psychosis in the Immigrant Caribbean Population. International Journal of Social Psychiatry 57:5, pages 462-470.
Crossref
James Richard Burgdorf, Beau Kilmer & Rosalie Liccardo Pacula. (2011) Heterogeneity in the composition of marijuana seized in California. Drug and Alcohol Dependence 117:1, pages 59-61.
Crossref
Beng-Choon Ho, Thomas H. Wassink, Steven Ziebell & Nancy C. Andreasen. (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophrenia Research 128:1-3, pages 66-75.
Crossref
Paul D Morrison, Judith Nottage, James M Stone, Sagnik Bhattacharyya, Nigel Tunstall, Rudolf Brenneisen, David Holt, Daniel Wilson, Alex Sumich, Philip McGuire, Robin M Murray, Shitij Kapur & Dominic H ffytche. (2010) Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms. Neuropsychopharmacology 36:4, pages 827-836.
Crossref
Aram Kim & Mary O'Hanlon. (2014) Caffeine and clinical change in a patient with schizophrenia on a long-stay ward. Irish Journal of Psychological Medicine 28:1, pages 42-44.
Crossref
Daniel J. Fridberg, Jennifer M. Vollmer, Brian F. O'Donnell & Patrick D. Skosnik. (2011) Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Research 186:1, pages 46-52.
Crossref
Chad A. Bousman, Stephen J. Glatt, Ian P. Everall & Ming T. Tsuang. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume I. Handbook of Schizophrenia Spectrum Disorders, Volume I 327 343 .
Claire E. Ramsay & Michael T. Compton. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume III. Handbook of Schizophrenia Spectrum Disorders, Volume III 289 320 .
Anne Emilia Tammimäki & Pekka T. Männistö. (2010) Are genetic variants of COMT associated with addiction?. Pharmacogenetics and Genomics 20:12, pages 717-741.
Crossref
Diane Lévy-Chavagnat. (2010) Cannabis et schizophrénie : des liens reconnus. Actualités Pharmaceutiques 49:498, pages 30-34.
Crossref
Daniela Parolaro, Natalia Realini, Daniela Vigano, Cinzia Guidali & Tiziana Rubino. (2010) The endocannabinoid system and psychiatric disorders. Experimental Neurology 224:1, pages 3-14.
Crossref
Chiayu Q. Chiu, Nagore Puente, Pedro Grandes & Pablo E. Castillo. (2010) Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex. The Journal of Neuroscience 30:21, pages 7236-7248.
Crossref
Alessandra Diehl, Daniel Cruz Cordeiro & Ronaldo Laranjeira. (2010) Abuso de cannabis em pacientes com transtornos psiquiátricos: atualização para uma antiga evidência. Revista Brasileira de Psiquiatria 32:suppl 1, pages 541-545.
Crossref
R. Andrew Sewell, Patrick D. Skosnik, Icelini Garcia-Sosa, Mohini Ranganathan & Deepak Cyril D'Souza. (2010) Efeitos comportamentais, cognitivos e psicofisiológicos dos canabinoides: relevância para a psicose e a esquizofrenia. Revista Brasileira de Psiquiatria 32:suppl 1, pages 515-530.
Crossref
William E. Greineisen & Helen Turner. (2010) Immunoactive effects of cannabinoids: Considerations for the therapeutic use of cannabinoid receptor agonists and antagonists. International Immunopharmacology 10:5, pages 547-555.
Crossref
Michael S. Ritsner. 2010. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Brain Protection in Schizophrenia, Mood and Cognitive Disorders 343 395 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.